{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T18:31:24Z","timestamp":1780597884417,"version":"3.54.1"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,4,5]],"date-time":"2019-04-05T00:00:00Z","timestamp":1554422400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Mol. Neurosci."],"DOI":"10.3389\/fnmol.2019.00080","type":"journal-article","created":{"date-parts":[[2019,4,5]],"date-time":"2019-04-05T12:14:54Z","timestamp":1554466494000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":38,"title":["Conditioned Medium of Human Menstrual Blood-Derived Endometrial Stem Cells Protects Against MPP+-Induced Cytotoxicity in vitro"],"prefix":"10.3389","volume":"12","author":[{"given":"Han","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Badrul Hisham","family":"Yahaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wai Hoe","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narazah Mohd","family":"Yusoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juntang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,4,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.juro.2013.08.026","article-title":"Effects of allogeneic bone marrow derived mesenchymal stromal cell therapy on voiding function in a rat model of Parkinson disease","volume":"191","author":"Campeau","year":"2014","journal-title":"J. Urol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"979","DOI":"10.5966\/sctm.2014-0146","article-title":"Proceedings: cell therapies for Parkinson\u2019s disease from discovery to clinic","volume":"3","author":"Canet-Aviles","year":"2014","journal-title":"Stem Cell. Transl. Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.cellimm.2017.06.006","article-title":"Mesenchymal stem cell-mediated immunomodulation in cell therapy of neurodegenerative diseases","volume":"326","author":"Chen","year":"2018","journal-title":"Cell. Immunol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1038\/mt.2014.206","article-title":"Enhanced efficacy of the CDNF\/MANF family by combined intranigral overexpression in the 6-OHDA rat model of Parkinson\u2019s disease","volume":"23","author":"Cordero-Llana","year":"2015","journal-title":"Mol. Ther."},{"key":"B5","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","article-title":"Parkinson\u2019s disease: mechanisms and models","volume":"39","author":"Dauer","year":"2003","journal-title":"Neuron"},{"key":"B6","doi-asserted-by":"publisher","first-page":"e80880","DOI":"10.1371\/journal.pone.0080880","article-title":"Co-transplantation of GDNF-overexpressing neural stem cells and fetal dopaminergic neurons mitigates motor symptoms in a rat model of Parkinson\u2019s disease","volume":"8","author":"Deng","year":"2013","journal-title":"PLoS One"},{"key":"B7","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1177\/0963689717753188","article-title":"A combination of NT-4\/5 and GDNF is favorable for cultured human nigral neural progenitor cells","volume":"27","author":"Di Santo","year":"2018","journal-title":"Cell Transplant."},{"key":"B8","doi-asserted-by":"publisher","first-page":"16953","DOI":"10.1038\/srep16953","article-title":"Adipose-derived stem cell conditioned media extends survival time of a mouse model of amyotrophic lateral sclerosis","volume":"5","author":"Fontanilla","year":"2015","journal-title":"Sci. Rep."},{"key":"B9","doi-asserted-by":"publisher","first-page":"e0149776","DOI":"10.1371\/journal.pone.0149776","article-title":"Comparative analysis of the effects of neurotrophic factors CDNF and GDNF in a nonhuman primate model of Parkinson\u2019s disease","volume":"11","author":"Garea-Rodr\u00edguez","year":"2016","journal-title":"PLoS One"},{"key":"B10","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.neulet.2013.02.057","article-title":"Adipose stromal cells-conditioned medium blocks 6-hydroxydopamine-induced neurotoxicity and reactive oxygen species","volume":"544","author":"Gu","year":"2013","journal-title":"Neurosci. Lett."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainres.2008.12.016","article-title":"Combined treatment of neurotrophin-3 gene and neural stem cells is ameliorative to behavior recovery of Parkinson\u2019s disease rat model","volume":"1257","author":"Gu","year":"2009","journal-title":"Brain Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.neuroscience.2015.07.014","article-title":"GDNF-secreting mesenchymal stem cells provide localized neuroprotection in an inflammation-driven rat model of Parkinson\u2019s disease","volume":"303","author":"Hoban","year":"2015","journal-title":"Neuroscience"},{"key":"B13","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.expneurol.2011.10.021","article-title":"Hepatocyte growth factor reduces astrocytic scar formation and promotes axonal growth beyond glial scars after spinal cord injury","volume":"233","author":"Jeong","year":"2012","journal-title":"Exp. Neurol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/term.504","article-title":"Transplantation of porcine umbilical cord matrix mesenchymal stem cells in a mouse model of Parkinson\u2019s disease","volume":"7","author":"Kang","year":"2013","journal-title":"J. Tissue Eng. Regen. Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"5207","DOI":"10.1016\/j.bmcl.2017.10.048","article-title":"Acacetin inhibits neuronal cell death induced by 6-hydroxydopamine in cellular Parkinson\u2019s disease model","volume":"27","author":"Kim","year":"2017","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"B16","doi-asserted-by":"publisher","first-page":"e27706","DOI":"10.1371\/journal.pone.0027706","article-title":"Human hepatocyte growth factor promotes functional recovery in primates after spinal cord injury","volume":"6","author":"Kitamura","year":"2011","journal-title":"PLoS One"},{"key":"B17","doi-asserted-by":"publisher","first-page":"8316","DOI":"10.1038\/s41598-018-26704-x","article-title":"Hepatocyte growth factor (HGF) promotes peripheral nerve regeneration by activating repair schwann cells","volume":"8","author":"Ko","year":"2018","journal-title":"Sci. Rep."},{"key":"B18","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.jcyt.2015.11.007","article-title":"Dopaminergic-primed fetal liver mesenchymal stromal-like cells can reverse parkinsonian symptoms in 6-hydroxydopamine-lesioned mice","volume":"18","author":"Kumar","year":"2016","journal-title":"Cytotherapy"},{"key":"B19","doi-asserted-by":"publisher","first-page":"501","DOI":"10.5604\/01.3001.0011.7395","article-title":"Therapeutic effect of HGF on NASH mice through HGF\/c-Met and JAK2-STAT3 signalling pathway","volume":"17","author":"Li","year":"2018","journal-title":"Ann. Hepatol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.parkreldis.2006.07.015","article-title":"Dopaminergic neuroprotection by neurturin-expressing c17.2 neural stem cells in a rat model of Parkinson\u2019s disease","volume":"13","author":"Liu","year":"2007","journal-title":"Parkinsonism Relat. Disord."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1111\/jcmm.13437","article-title":"Biological characteristics of human menstrual blood-derived endometrial stem cells","volume":"22","author":"Liu","year":"2018","journal-title":"J. Cell. Mol. Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/s0006-8993(02)03222-5","article-title":"Nerve growth factor levels in Parkinson disease and experimental parkinsonian rats","volume":"952","author":"Lorigados Pedre","year":"2002","journal-title":"Brain Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.expneurol.2007.10.011","article-title":"Autologous transplants of adipose-derived adult stromal (ADAS) afford dopaminergic neuroprotection in a model of Parkinson\u2019s disease","volume":"210","author":"McCoy","year":"2008","journal-title":"Exp. Neurol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.neuroscience.2014.05.019","article-title":"Neurotrophic and neuroprotective efficacy of intranasal GDNF in a rat model of Parkinson\u2019s disease","volume":"274","author":"Migliore","year":"2014","journal-title":"Neuroscience"},{"key":"B25","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1111\/j.1440-1746.2010.06549.x","article-title":"Hepatocyte growth factor twenty years on: much more than a growth factor","volume":"26","author":"Nakamura","year":"2011","journal-title":"J. Gastroenterol. Hepatol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"e64723","DOI":"10.1371\/journal.pone.0064723","article-title":"Adult bone marrow neural crest stem cells and mesenchymal stem cells are not able to replace lost neurons in acute MPTP-lesioned mice","volume":"8","author":"Neirinckx","year":"2013","journal-title":"PLoS One"},{"key":"B27","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/s0006-8993(02)02934-7","article-title":"Dopaminergic neuroprotection and regeneration by neurturin assessed by using behavioral, biochemical and histochemical measurements in a model of progressive Parkinson\u2019s disease","volume":"947","author":"Oiwa","year":"2002","journal-title":"Brain Res."},{"key":"B28","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1007\/s10753-018-0747-1","article-title":"HGF reduces disease severity and inflammation by attenuating the NF-\u03baB signaling in a rat model of pulmonary artery hypertension","volume":"41","author":"Pang","year":"2018","journal-title":"Inflammation"},{"key":"B29","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/S0079-6123(10)84013-0","article-title":"Neurotrophic factor therapy for Parkinson\u2019s disease","volume":"184","author":"Rangasamy","year":"2010","journal-title":"Prog. Brain Res."},{"key":"B30","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.expneurol.2013.06.002","article-title":"AAV2-mediated striatum delivery of human CDNF prevents the deterioration of midbrain dopamine neurons in a 6-hydroxydopamine induced parkinsonian rat model","volume":"248","author":"Ren","year":"2013","journal-title":"Exp. Neurol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"13898","DOI":"10.1074\/jbc.M209164200","article-title":"Nerve growth factor protects against 6-hydroxydopamine-induced oxidative stress by increasing expression of heme oxygenase-1 in a phosphatidylinositol 3-kinase-dependent manner","volume":"278","author":"Salinas","year":"2003","journal-title":"J. Biol. Chem."},{"key":"B32","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.brainres.2017.05.015","article-title":"Nogo-receptor 1 antagonization in combination with neurotrophin-4\/5 is not superior to single factor treatment in promoting survival and morphological complexity of cultured dopaminergic neurons","volume":"1668","author":"Seiler","year":"2017","journal-title":"Brain Res."},{"key":"B33","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1002\/1097-4547(20010301)63:5<402::aid-jnr1035>3.0.co;2-f","article-title":"Nerve growth factor prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced cell death via the Akt pathway by suppressing caspase-3-like activity using PC12 cells: relevance to therapeutical application for parkinson\u2019s disease","volume":"63","author":"Shimoke","year":"2001","journal-title":"J. Neurosci. Res."},{"key":"B34","doi-asserted-by":"publisher","first-page":"521","DOI":"10.7868\/S0026898416040108","article-title":"Glial cell line-derived neurotrophic factor family ligands and their therapeutic potential","volume":"50","author":"Sidorova","year":"2016","journal-title":"Mol. Biol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"e72926","DOI":"10.1371\/journal.pone.0072926","article-title":"Therapeutic potential of mesenchymal stromal cells and MSC conditioned medium in amyotrophic lateral sclerosis (ALS)\u2014in vitro evidence from primary motor neuron cultures, NSC-34 cells, astrocytes and microglia","volume":"8","author":"Sun","year":"2013","journal-title":"PLoS One"},{"key":"B36","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1007\/s12264-017-0123-4","article-title":"Cerebral dopamine neurotrophic factor: a potential therapeutic agent for Parkinson\u2019s disease","volume":"33","author":"Tang","year":"2017","journal-title":"Neurosci. Bull."},{"key":"B37","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.nbd.2014.01.009","article-title":"Pharmacologically controlled, discontinuous GDNF gene therapy restores motor function in a rat model of Parkinson\u2019s disease","volume":"65","author":"Tereshchenko","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"B38","doi-asserted-by":"publisher","first-page":"118","DOI":"10.3390\/cells8020118","article-title":"Mesenchymal stem cells-derived exosomes: a new possible therapeutic strategy for Parkinson\u2019s disease?","volume":"8","author":"Vila\u00e7a-Faria","year":"2019","journal-title":"Cells"},{"key":"B39","doi-asserted-by":"publisher","first-page":"3739","DOI":"10.1016\/j.febslet.2015.09.031","article-title":"Therapeutic potential of the endoplasmic reticulum located and secreted CDNF\/MANF family of neurotrophic factors in Parkinson\u2019s disease","volume":"589","author":"Voutilainen","year":"2015","journal-title":"FEBS Lett."},{"key":"B40","doi-asserted-by":"publisher","first-page":"e0179476","DOI":"10.1371\/journal.pone.0179476","article-title":"Therapeutic efficacy of AAV8-mediated intrastriatal delivery of human cerebral dopamine neurotrophic factor in 6-OHDA-induced parkinsonian rat models with different disease progression","volume":"12","author":"Wang","year":"2017","journal-title":"PLoS One"},{"key":"B41","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1634\/stemcells.2008-0333","article-title":"IFATS collection: the conditioned media of adipose stromal cells protect against hypoxia-ischemia-induced brain damage in neonatal rats","volume":"27","author":"Wei","year":"2009","journal-title":"Stem Cells"},{"key":"B100","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1111\/j.1582-4934.2010.01068.x","article-title":"Endometrial stem cell transplantation restores dopamine production in a Parkinson\u2019s disease model","volume":"15","author":"Wolff","year":"2011","journal-title":"J. Cell. Mol. Med."},{"key":"B42","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1111\/jcmm.12433","article-title":"Endometrial stem cell transplantation in MPTP- exposed primates: an alternative cell source for treatment of Parkinson\u2019s disease","volume":"19","author":"Wolff","year":"2015","journal-title":"J. Cell. Mol. Med."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1177\/0963689717735411","article-title":"Cell therapy for Parkinson\u2019s disease","volume":"26","author":"Yasuhara","year":"2017","journal-title":"Cell Transplant."},{"key":"B44","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.brainres.2006.12.061","article-title":"Transplantation of bone marrow stromal cells containing the neurturin gene in rat model of Parkinson\u2019s disease","volume":"1142","author":"Ye","year":"2007","journal-title":"Brain Res."},{"key":"B45","doi-asserted-by":"publisher","first-page":"e105118","DOI":"10.1371\/journal.pone.0105118","article-title":"The effect of lentivirus-mediated PSPN genetic engineering bone marrow mesenchymal stem cells on Parkinson\u2019s disease rat model","volume":"9","author":"Yin","year":"2014","journal-title":"PLoS One"},{"key":"B46","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.neulet.2009.01.025","article-title":"Adipose stromal cells-conditional medium protected glutamate-induced CGNs neuronal death by BDNF","volume":"452","author":"Zhao","year":"2009","journal-title":"Neurosci. Lett."},{"key":"B47","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.brainresbull.2004.10.012","article-title":"The GDNF family members neurturin, artemin and persephin promote the morphological differentiation of cultured ventral mesencephalic dopaminergic neurons","volume":"68","author":"Zihlmann","year":"2005","journal-title":"Brain Res. Bull."}],"container-title":["Frontiers in Molecular Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fnmol.2019.00080\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,5]],"date-time":"2019-04-05T12:14:59Z","timestamp":1554466499000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fnmol.2019.00080\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,5]]},"references-count":48,"alternative-id":["10.3389\/fnmol.2019.00080"],"URL":"https:\/\/doi.org\/10.3389\/fnmol.2019.00080","relation":{},"ISSN":["1662-5099"],"issn-type":[{"value":"1662-5099","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,5]]},"article-number":"80"}}